Oxygen-Generating Microbeads for Cell Viability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Cell-based implants face inadequate oxygenation due to the lack of a vascular network, leading to hypoxia-induced cell death and dysfunction, particularly in larger implants that cannot vascularize, such as macroencapsulation or immunoisolatory platforms, with existing oxygen generation technologies limited by geometrical constraints, injectability, and release profiles.
Innovation Solution
Development of spherical microbeads with a hydrophobic polymeric support structure containing solid oxygen-generating peroxide particles, allowing for extended release of oxygen over 1 week or more, and optionally incorporating porogens and therapeutic agents for simultaneous delivery, with customizable release profiles and geometric flexibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If cell-based implants are made larger than 200 μm to support more cells, then cell capacity is improved, but oxygenation becomes inadequate due to lack of vascular network
Solution Approach 1:
The patent extracts the oxygen generation function from the vascular network by incorporating solid oxygen-generating peroxide particles directly into the implant matrix. This allows large-scale cell support without requiring functional blood vessels, directly resolving the contradiction between implant size and oxygenation.
Solution Approach 2:
The patent introduces oxygen-generating peroxide particles as an intermediary substance that provides oxygen locally within the implant. This mediator bridges the gap between the lack of vascular network and the need for oxygenation, enabling large implant sizes without hypoxia.
2Quantity of substance
If conventional oxygen generation technologies are used, then oxygen supply is provided, but geometrical constraints and lack of injectability limit application flexibility
Solution Approach 1:
The patent changes the physical form of oxygen-generating materials from rigid structures to soft, injectable microbeads containing peroxide particles. This parameter change enables geometric flexibility and adaptability to various implant configurations while maintaining oxygen supply function.
Solution Approach 2:
The patent segments the oxygen generation system into discrete microbead units that can be freely distributed and injected. This segmentation provides geometric flexibility and adaptability compared to conventional monolithic oxygen generation systems.
3Reliability
If oxygen release is increased to combat hypoxia, then cell viability is improved, but release profile control becomes insufficient leading to premature depletion
Solution Approach 1:
The patent employs a porous matrix structure to encapsulate oxygen-generating peroxide particles. The porous architecture controls oxygen release by regulating water diffusion and peroxide decomposition rates, providing sustained oxygen supply over extended periods while maintaining high cell viability.
Solution Approach 2:
The patent creates a composite material system combining peroxide particles, porous matrix, and hydrogel components. This composite structure enables controlled, sustained oxygen release profiles that prevent premature depletion while maintaining reliable cell viability support.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microbeads provide sustained oxygen delivery to cells, reducing hypoxia-induced cell death and enhancing cell viability and functionality, as demonstrated by increased metabolic activity and insulin content in both in vitro and in vivo studies, supporting the integration of cells in cellular implants.
Implementation Method 1
The microbead has a hydrophobic polymeric support structure containing solid oxygen-generating peroxide particles
Implementation Method 2
The rate of water diffusion through the matrix and subsequent oxygen generation by the peroxide particles
Data Source
AI summary
The present disclosure provides for spherical microbeads, methods of making, and methods of use. The spherical microbeads can be tailored to deliver one or more agents over a desired time frame (e.g., short burst or extended-release or combinations thereof). For example, spherical microbeads can be used for the extended-release of oxygen. The spherical microbeads are amendable for an injectable approach and/or ease of integration within cellular implants due in part to their spherical dimensions and size.